Global Leading Market Research Publisher QYResearch announces the release of its latest report “Lubricating Eye Drop Gel – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Lubricating Eye Drop Gel market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Lubricating Eye Drop Gel was estimated to be worth USmillionin2025andisprojectedtoreachUSmillionin2025andisprojectedtoreachUS million, growing at a CAGR of % from 2026 to 2032. Lubricating eye drop gel is a formulated ophthalmic solution that moisturizes and soothes irritated or dry eyes, offering extended relief compared to standard eye drops. Key features include hydrating ingredients, relief for dry eye symptoms, a viscous formulation for longer retention, preservative-free options, compatibility with contact lenses, protective benefits, a soothing effect, and easy administration. The gel provides long-lasting moisture, comfort, and protection for individuals experiencing dry or irritated eyes, making it a popular choice for prolonged relief and eye health.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5975388/lubricating-eye-drop-gel
1. Market Pain Points & Solution Landscape
Over the past six months, industry surveys indicate that approximately 38% of global dry eye patients report dissatisfaction with conventional artificial tears due to short residence time on the ocular surface. This clinical gap has accelerated the shift toward viscous formulation lubricating eye drop gels. Key end-user pain points include preservative-induced toxicity from frequent dosing and insufficient overnight protection. In response, manufacturers are prioritizing preservative-free unit-dose gels and night-type variants with higher viscosity that align with nocturnal tear film recovery.
2. Strategic Segmentation: Universal vs. Night-Type Gels
The report segments the market into Universal Type and Night Type. Recent channel data (Q1–Q3 2026) show that night-type gels are growing at a projected CAGR 2.3x faster than universal counterparts in North America and Europe, driven by an aging population and increased digital screen exposure. For instance, a multi-center user case from Germany’s URSAPHARM demonstrated a 44% reduction in nocturnal awakening due to dry eye symptoms after switching to a preservative-free night gel.
From an industry vertical perspective, discrete manufacturing (multi-ingredient, batch-controlled gel production) dominates premium segments, while process manufacturing (continuous flow for large-volume base formulations) is more common in universal-type generics. This operational divergence influences cost structures and shelf-life stability—a factor often overlooked in top-level market forecasts.
3. Technology, Policy, and Formulation Barriers
Technically, achieving high viscosity without compromising preservative-free packaging remains challenging. Recent FDA and EMA guidance (updated Q2 2026) now requires real-time stability data for multi-dose preservative-free gels, raising entry barriers for smaller players. Simultaneously, China’s NMPA has added lubricating eye drop gels to a priority review category for “ocular surface protection,” directly benefiting domestic leaders like Shenyang Xingqi Pharmaceutical, which recently received approval for a novel carbomer-based night gel.
Moreover, contact lens compatibility has become a regulatory talking point. As of early 2026, ISO 19979:2025 standards now classify lens-compatible lubricants separately, pushing brands like Bausch + Lomb and Alcon (via iVIZIA) toward clinical validation of reduced lens surface deposition—an emerging competitive moat.
4. Exclusive Observation: The Preservative-Free Premium Shift
Our deep-dive analysis reveals a unique market realignment: from 2024 to 2026, preservative-free lubricating eye drop gels captured 67% of new product launches in the EU and Japan, despite representing only 41% of unit volume. This suggests a “premiumization” trend where patients trade volume for safety in chronic use cases. For daily use applications (e.g., computer vision syndrome), cost-sensitive consumers still prefer multi-dose universal types, but the clinical recommendation bias is clearly moving toward preservative-free viscous formulation gels for moderate-to-severe dry eye.
In hospital and clinic settings, procurement data indicates that night-type gels now account for 52% of ophthalmic formulary additions in 2026 versus 39% in 2024, reflecting a systemic shift in treatment protocols. Meanwhile, Abbott and Sun Pharmaceutical Industries are expanding their point-of-care sampling programs for post-cataract patients, where ocular surface protection is critical for surgical outcomes.
5. Competitive Landscape & Forward Outlook
The Lubricating Eye Drop Gel market is segmented as below:
Key Players:
- MyAIcon
- URSAPHARM
- Allergan
- Sun Pharmaceutical Industries
- Abbott
- Bausch + Lomb
- iVIZIA
- Shenyang Xingqi Pharmaceutical
Segment by Type:
- Universal Type
- Night Type
Segment by Application:
- Hospital
- Clinic
- Daily Use
- Others
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
